|
|
|
40
|
1131EP
|
ROSUVASTATIN 5MG TAB (MSN/AHI)
|
ROSUVASTATIN
|
ROSUVASTATIN
|
30'S
|
A
|
2.47
|
0.08
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
41
|
1131FA
|
ATOREM 10MG TAB (MSN) ATORVASTATIN
|
ATORVASTATIN
|
ATOREM
|
3X10
|
A
|
1.2
|
0.0399
|
TAB
|
30
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
1131HT
|
ATOREM 10MG TAB (MSN) ATORVASTATIN
|
ATORVASTATIN
|
ATOREM
|
3X10
|
A
|
1.06
|
0.04
|
TAB
|
30
|
|
MSN
|
MSN LABS
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-03-23
|
|
|
|
40
|
1132FW
|
ROSUVASTATIN 10MG TAB (MSN/AHI)
|
ROSUVASTATIN
|
ROSUVASTATIN
|
30'S
|
A
|
4.08
|
0.14
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
41
|
1132GL
|
ROSUVASTATIN 10MG TAB (MSN)
|
ROSUVASTATIN
|
ROSUVASTATIN
|
30'S
|
A
|
2.58
|
0.0861
|
TAB
|
30
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
1132KM
|
ATOREM 20MG TAB (MSN) ATORVASTATIN
|
ATORVASTATIN
|
ATOREM
|
3X10
|
A
|
1.60
|
0.05
|
TAB
|
30
|
BLIS
|
MSN
|
MSN LABS
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-03-24
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-03-23
|
|
|
|
40
|
1133EH
|
ROSUVASTATIN 20MG TAB (MSN/AHI)
|
ROSUVASTATIN
|
ROSUVASTATIN
|
30'S
|
A
|
5.16
|
0.17
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-03-29
|
|
|
|
41
|
1133FB
|
LDNIL 20MG TAB (MSN) ROSUVASTATIN
|
ROSUVASTATIN
|
LDNIL
|
30'S
|
A
|
3.86
|
0.1287
|
TAB
|
30
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
1134AT
|
ATORVASTATIN 80MG TAB (MSN)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
5.76
|
0.1921
|
TAB
|
30
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
1134AU
|
LDNIL 40MG TAB (MSN) ROSUVASTATIN
|
ROSUVASTATIN
|
LDNIL
|
30'S
|
A
|
6.31
|
0.2102
|
TAB
|
30
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
21435
|
EPNONE 50MG TAB (MSN) EPLERENONE (B)
|
EPLERENONE
|
EPNONE
|
30'S
|
B
|
21.39
|
0.7131
|
TAB
|
60
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
41
|
21436
|
EPNONE 25MG TAB (MSN) EPLERENONE (B)
|
EPLERENONE
|
EPNONE
|
30'S
|
B
|
12.64
|
0.4213
|
TAB
|
60
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
243220
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ALDOSTERONE RECEPTOR ANTAGONIST
|
|
|
|
|
40
|
2841EZ
|
METSAFE ER 500MG TAB (MSN/ATB) METFORMIN XR
|
METFORMIN XR
|
METSAFE ER
|
10X10
|
A
|
4.84
|
0.05
|
TABLET
|
120
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
682004
|
BIGUANIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
2843F
|
METSAFE ER 1G TAB (MSN/ATB) METFORMIN XR
|
METFORMIN XR
|
METSAFE ER
|
100'S
|
A
|
9.70
|
0.10
|
TABLET
|
60
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
682004
|
BIGUANIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2843F
|
METSAFE 1G ER TAB (MSN) METFORMIN XR
|
METFORMIN XR
|
METSAFE
|
100'S
|
A
|
13.18
|
0.1318
|
TABER
|
60
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
682004
|
BIGUANIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
BIGUANIDES
|
|
|
|
|
40
|
3921CK
|
PLASEP 75MG TAB (MSN/ATB) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
1.77
|
0.06
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-04-01
|
2022-07-26
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
40
|
3921CK
|
PLASEP 75MG TAB (MSN/ATB) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.16
|
0.07
|
TABLET
|
30
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-09-06
|
2024-03-31
|
Price Change
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-07-26
|
|
|
|
41
|
3921CK
|
PLASEP 75MG TAB (MSN) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.64
|
0.0879
|
TAB
|
30
|
BOX
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921ER
|
PLASEP 75MG TAB (MSN) CLOPIDOGREL
|
CLOPIDOGREL
|
PLASEP
|
3X10
|
A
|
2.47
|
0.08
|
TAB
|
30
|
|
MSN
|
MSN LABS
|
STO
|
BRYDEN STOKES LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
2026-03-23
|
|
|
|
41
|
4332U
|
TYKONIB 400MG TAB (MSN) (BQ)
|
IMATINIB
|
TYKONIB
|
30'S
|
BQ
|
117.02
|
3.9008
|
TAB
|
60
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|